Charles Schwab’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $482M | Sell |
2,181,318
-25,868
| -1% | -$7.16M | 0.06% | 245 |
|
|
2026
Q1 | $652M | Buy |
2,207,186
+59,025
| +3% | +$17.5M | 0.1% | 165 |
|
|
2025
Q4 | $587M | Buy |
2,148,161
+26,845
| +1% | +$7.29M | 0.09% | 184 |
|
|
2025
Q3 | $573M | Buy |
2,121,316
+11,635
| +0.6% | +$3.17M | 0.09% | 184 |
|
|
2025
Q2 | $581M | Buy |
2,109,681
+28,658
| +1% | +$7.79M | 0.1% | 172 |
|
|
2025
Q1 | $552M | Buy |
2,081,023
+33,336
| +2% | +$8.22M | 0.1% | 174 |
|
|
2024
Q4 | $476M | Buy |
2,047,687
+65,726
| +3% | +$15.1M | 0.09% | 189 |
|
|
2024
Q3 | $437M | Buy |
1,981,961
+26,642
| +1% | +$5.51M | 0.08% | 200 |
|
|
2024
Q2 | $384M | Buy |
1,955,319
+33,962
| +2% | +$7.02M | 0.07% | 227 |
|
|
2024
Q1 | $414M | Buy |
1,921,357
+26,272
| +1% | +$5.52M | 0.1% | 186 |
|
|
2023
Q4 | $399M | Sell |
1,895,085
-35,695
| -2% | -$7.62M | 0.1% | 164 |
|
|
2023
Q3 | $387M | Buy |
1,930,780
+18,928
| +1% | +$3.76M | 0.11% | 155 |
|
|
2023
Q2 | $354M | Sell |
1,911,852
-8,246
| -0.4% | -$1.52M | 0.1% | 171 |
|
|
2023
Q1 | $368M | Buy |
1,920,098
+21,444
| +1% | +$3.88M | 0.11% | 157 |
|
|
2022
Q4 | $319M | Buy |
1,898,654
+46,046
| +2% | +$8M | 0.1% | 179 |
|
|
2022
Q3 | $328M | Buy |
1,852,608
+167,784
| +10% | +$33.2M | 0.12% | 161 |
|
|
2022
Q2 | $345M | Buy |
1,684,824
+17,907
| +1% | +$3.8M | 0.12% | 155 |
|
|
2022
Q1 | $396M | Buy |
1,666,917
+43,142
| +3% | +$10.1M | 0.12% | 149 |
|
|
2021
Q4 | $371M | Buy |
1,623,775
+42,571
| +3% | +$9.37M | 0.11% | 162 |
|
|
2021
Q3 | $306M | Buy |
1,581,204
+20,652
| +1% | +$4.18M | 0.1% | 177 |
|
|
2021
Q2 | $332M | Buy |
1,560,552
+35,512
| +2% | +$7.5M | 0.11% | 161 |
|
|
2021
Q1 | $311M | Buy |
1,525,040
+36,235
| +2% | +$7.14M | 0.11% | 157 |
|
|
2020
Q4 | $271M | Buy |
1,488,805
+19,457
| +1% | +$3.31M | 0.11% | 173 |
|
|
2020
Q3 | $246M | Sell |
1,469,348
-113,337
| -7% | -$19.1M | 0.11% | 166 |
|
|
2020
Q2 | $257M | Buy |
1,582,685
+20,807
| +1% | +$3.73M | 0.13% | 151 |
|
|
2020
Q1 | $270M | Buy |
1,561,878
+15,920
| +1% | +$3.17M | 0.16% | 128 |
|
|
2019
Q4 | $310M | Buy |
1,545,958
+24,903
| +2% | +$5.11M | 0.17% | 108 |
|
|
2019
Q3 | $321M | Buy |
1,521,055
+41,207
| +3% | +$8.61M | 0.19% | 98 |
|
|
2019
Q2 | $287M | Buy |
1,479,848
+44,574
| +3% | +$8.22M | 0.17% | 106 |
|
|
2019
Q1 | $236M | Buy |
1,435,274
+47,393
| +3% | +$8.38M | 0.15% | 123 |
|
|
2018
Q4 | $261M | Buy |
1,387,881
+100,080
| +8% | +$18.5M | 0.2% | 93 |
|
|
2018
Q3 | $219M | Buy |
1,287,801
+79,831
| +7% | +$13.4M | 0.15% | 127 |
|
|
2018
Q2 | $198M | Buy |
1,207,970
+37,225
| +3% | +$6.08M | 0.14% | 132 |
|
|
2018
Q1 | $189M | Sell |
1,170,745
-540,378
| -32% | -$86M | 0.15% | 131 |
|
|
2017
Q4 | $250M | Buy |
1,711,123
+89,480
| +6% | +$12.7M | 0.2% | 86 |
|
|
2017
Q3 | $220M | Buy |
1,621,643
+49,352
| +3% | +$6.23M | 0.19% | 92 |
|
|
2017
Q2 | $197M | Buy |
1,572,291
+68,952
| +5% | +$8.25M | 0.19% | 101 |
|
|
2017
Q1 | $179M | Buy |
1,503,339
+93,388
| +7% | +$11.2M | 0.18% | 102 |
|
|
2016
Q4 | $163M | Buy |
1,409,951
+28,637
| +2% | +$3.19M | 0.18% | 110 |
|
|
2016
Q3 | $144M | Buy |
1,381,314
+91,274
| +7% | +$9.53M | 0.17% | 109 |
|
|
2016
Q2 | $126M | Buy |
1,290,040
+71,370
| +6% | +$6.74M | 0.16% | 122 |
|
|
2016
Q1 | $117M | Buy |
1,218,670
+362,281
| +42% | +$33M | 0.15% | 126 |
|
|
2015
Q4 | $77.6M | Buy |
856,389
+32,218
| +4% | +$3.03M | 0.1% | 180 |
|
|
2015
Q3 | $76.4M | Buy |
824,171
+45,968
| +6% | +$4.37M | 0.11% | 175 |
|
|
2015
Q2 | $72.4M | Buy |
778,203
+20,174
| +3% | +$1.88M | 0.1% | 195 |
|
|
2015
Q1 | $71.8M | Buy |
758,029
+25,312
| +3% | +$2.34M | 0.1% | 198 |
|
|
2014
Q4 | $65M | Buy |
732,717
+29,696
| +4% | +$2.52M | 0.1% | 201 |
|
|
2014
Q3 | $56.2M | Buy |
703,021
+15,853
| +2% | +$1.19M | 0.09% | 212 |
|
|
2014
Q2 | $48.8M | Buy |
687,168
+39,578
| +6% | +$2.79M | 0.08% | 240 |
|
|
2014
Q1 | $47.9M | Buy |
647,590
+15,213
| +2% | +$1.15M | 0.09% | 227 |
|
|
2013
Q4 | $49.6M | Buy |
632,377
+27,069
| +4% | +$2.12M | 0.09% | 207 |
|
|
2013
Q3 | $45.3M | Buy |
605,308
+25,817
| +4% | +$1.9M | 0.09% | 218 |
|
|
2013
Q2 | $44.3M | Buy |
+579,491
| New | +$38M | 0.1% | 206 |
|
Other funds holding CME
Charles Schwab's CME Position: Q2 2026 in Review
Charles Schwab reduced its CME Group (CME) stake by 1.2% in Q2 2026, selling an estimated $7.16M and leaving 2,181,318 shares worth $482M. The position accounts for 0.06% of the portfolio, ranked #245.
Charles Schwab first reported a position in CME in Q2 2013 and has held it in 53 quarters since. The position peaked at $652M in Q1 2026. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Charles Schwab held 2,181,318 shares of CME Group worth $482M as of Q2 2026.
- Charles Schwab sold 25,868 CME Group shares in Q2 2026, an estimated $7.16M.
- CME Group made up 0.06% of Charles Schwab's portfolio in Q2 2026, its #245 holding.
- Charles Schwab first reported a position in CME Group in Q2 2013 and has held it in 53 quarters since.
- Charles Schwab's CME Group position peaked at $652M in Q1 2026.
- 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.